GlassScriptPhysician profile
Gary R Skankey
NPI 1952386468
$3,667.13
in general payments reported to CMS, 2019-2025
17 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $251 · 2021: $715 · 2022: $752 · 2023: $444 · 2024: $510 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $983.61 | 2021-2025 | Dalvance, Avycaz, Teflaro |
| Merck Sharp & Dohme LLC | $632.70 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Melinta Therapeutics, LLC | $478.92 | 2019-2024 | Rezzayo, Vabomere |
| Allergan, INC. | $278.98 | 2019-2020 | |
| Shionogi INC | $226.14 | 2021-2025 | Fetroja |
| Janssen Products, LP | $198.95 | 2021-2022 | |
| Viiv Healthcare Company | $186.27 | 2019-2022 | |
| Insmed, INC. | $186.03 | 2019-2025 | Arikayce |
| Paratek Pharmaceuticals, INC. | $164.05 | 2019-2024 | Nuzyra |
| Astellas Pharma US INC | $125.13 | 2022 | |
| Janssen Biotech, INC. | $91.03 | 2019-2022 | |
| Pfizer INC. | $39.18 | 2023-2024 | |
| Aimmune Therapeutics, INC. | $22.21 | 2025 | Vowst |
| Oxford Immunotec USA INC | $16.81 | 2020 | |
| Tactile Systems Technology INC | $12.98 | 2023 | Entre Plus, Flexitouch Plus |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $12.50 | 2019 | |
| Theratechnologies INC. | $11.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Skankey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.